{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T17:10:11Z","timestamp":1683652211756},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.vaccine.2006.08.038","type":"journal-article","created":{"date-parts":[[2006,11,2]],"date-time":"2006-11-02T16:40:16Z","timestamp":1162485616000},"page":"605-611","source":"Crossref","is-referenced-by-count":2,"title":["Response and persistence of antibodies to PRP-T and DTwP vaccines with concomitant administration of conjugate vaccines"],"prefix":"10.1016","volume":"25","author":[{"given":"Arnaldo F.","family":"Ocampo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christel","family":"Biltoft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilla","family":"Lucero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose-Marie","family":"\u00d6lander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanita","family":"Ugpo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Auranen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu","family":"Soininen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Nohynek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"K\u00e4yhty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.08.038_bib1","unstructured":"Lucero M. Effectiveness of an 11-valent pneumococcal conjugate vaccine for preventing radiographically confirmed pneumonia in children under 2 years of age: a randomized, double-blind, placebo-controlled trial in the Philippines. In: 12th International Society for Infectious Diseases; 2006 June 15\u201318; Lisbon, Portugal; 2006."},{"issue":"9465","key":"10.1016\/j.vaccine.2006.08.038_bib2","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial","volume":"365","author":"Cutts","year":"2005","journal-title":"Lancet"},{"issue":"9381","key":"10.1016\/j.vaccine.2006.08.038_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(03)14022-6","article-title":"Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial","volume":"362","author":"O\u2019Brien","year":"2003","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.vaccine.2006.08.038_bib4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2006.08.038_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2006.08.038_bib6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/infdis\/169.2.479","article-title":"Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Filipino children","volume":"169","author":"Capeding","year":"1994","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2006.08.038_bib7","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/IAI.66.5.2093-2098.1998","article-title":"Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants","volume":"66","author":"Dagan","year":"1998","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2006.08.038_bib8","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00006454-199110000-00009","article-title":"The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at 2, 4 and 6 months of age","volume":"10","author":"Ferreccio","year":"1991","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.vaccine.2006.08.038_bib9","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00006454-199308000-00003","article-title":"Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at 2, 4 and 6 months of age","volume":"12","author":"Avendano","year":"1993","journal-title":"Pediatr Infect Dis J"},{"issue":"9195","key":"10.1016\/j.vaccine.2006.08.038_bib10","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(99)04377-9","article-title":"Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis","volume":"354","author":"Eskola","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2006.08.038_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/jama.267.5.673","article-title":"Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine","volume":"267","author":"Clemens","year":"1992","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.vaccine.2006.08.038_bib12","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/00006454-199110000-00008","article-title":"Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants","volume":"10","author":"Watemberg","year":"1991","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.vaccine.2006.08.038_bib13","first-page":"1105","article-title":"Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?","volume":"149","author":"Scheifele","year":"1993","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.vaccine.2006.08.038_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-3476(94)70328-0","article-title":"Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infants","volume":"124","author":"Kaplan","year":"1994","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.vaccine.2006.08.038_bib15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00006454-199405000-00004","article-title":"Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at 2, 4 and 6 months of age","volume":"13","author":"Gold","year":"1994","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2006.08.038_bib16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00006454-199405000-00005","article-title":"Safety and immunogenicity in young infants of Haemophilus b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis-enhanced inactivated poliovirus vaccine","volume":"13","author":"Dagan","year":"1994","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2006.08.038_bib17","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1542\/peds.95.4.522","article-title":"Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period","volume":"95","author":"Miller","year":"1995","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.vaccine.2006.08.038_bib18","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00006454-199709000-00009","article-title":"Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis\/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in 2-, 4- and 6-month-old infants","volume":"16","author":"Pichichero","year":"1997","journal-title":"Pediatr Infect Dis J"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2006.08.038_bib19","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1016\/S0264-410X(03)00389-X","article-title":"The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine","volume":"21","author":"Schmitt","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2006.08.038_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.inf.0000148923.46453.48","article-title":"Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine","volume":"24","author":"Tichmann-Schumann","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2006.08.038_bib21","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/00006454-200210000-00011","article-title":"Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine","volume":"21","author":"Obaro","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2006.08.038_bib22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00006454-199909000-00004","article-title":"Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers","volume":"18","author":"Shinefield","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.vaccine.2006.08.038_bib23","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1086\/420849","article-title":"Similar antibody concentrations in Filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria\/tetanus-conjugated vaccine: a randomized controlled trial","volume":"189","author":"Lucero","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.08.038_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2334-3-17","article-title":"Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein-conjugated pneumococcal vaccine in Filipino infants","volume":"3","author":"Capeding","year":"2003","journal-title":"BMC Infect Dis"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2006.08.038_bib25","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0264-410X(01)00375-9","article-title":"Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers","volume":"20","author":"Olander","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2006.08.038_bib26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/infdis\/155.1.100","article-title":"Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid","volume":"155","author":"Kayhty","year":"1987","journal-title":"J Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.08.038_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0022-1759(90)90264-V","article-title":"An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay","volume":"135","author":"Phipps","year":"1990","journal-title":"J Immunol Methods"},{"issue":"11","key":"10.1016\/j.vaccine.2006.08.038_bib28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1699-0463.1997.tb05093.x","article-title":"Improved ELISA for determination of anti-diphtheria and\/or anti-tetanus antitoxin antibodies in sera","volume":"105","author":"Kristiansen","year":"1997","journal-title":"APMIS"},{"key":"10.1016\/j.vaccine.2006.08.038_bib29","series-title":"Serological response to Bordetella pertussis","author":"Manclark","year":"1986"},{"key":"10.1016\/j.vaccine.2006.08.038_bib30","unstructured":"Philippine Health Statistics. Manila, Philippines, 1998."},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2006.08.038_bib31","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0264-410X(97)00276-4","article-title":"Antibody responses of three Haemophilus influenzae type b conjugate vaccines after one, two and three doses in Filipino children","volume":"16","author":"Capeding","year":"1998","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06009881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06009881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T16:29:45Z","timestamp":1683649785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06009881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0264410X06009881"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.08.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}